The opportunities and challenges of perioperative therapy of localized non-small cell lung cancer—thoughts from the KEYNOTE-671 trial
Nathaniel Deboever, Jianjun Zhang · 2023
Read The opportunities and challenges of perioperative therapy of localized non-small cell lung cancer—thoughts from the KEYNOTE-671 trial by Nathaniel Deboever, Jianjun Zhang (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10713268.txt.
Description
A peer-reviewed research article from Europe PMC (2023). Results from the phase II trial (NADIM II) evaluating the effect of perioperative nivolumab and chemotherapy have demonstrated significantly increased pathological complete response (pCR) in patients who received combination therapy compared to chemotherapy alone (5).
Catalog record
| CREATOR | Nathaniel Deboever, Jianjun Zhang |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 15 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |